Use of calcium channel antagonists in myocardial revascularization procedures

Calcium channel antagonists possess a number of properties that may be beneficial after revascularization procedures. Therefore, we present an overview of the use of these drugs after percutaneous intervention in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT), and compare the...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 1996-06, Vol.77 (16), p.26D-31D
Main Authors: Califf, Robert M., Tardiff, Barbara E., Pieper, Karen S., Hillegass, William B.
Format: Article
Language:English
Subjects:
Angioplasty, Balloon, Coronary
Antianginal agents. Coronary vasodilator agents
Atherectomy
Biological and medical sciences
Calcium
Calcium Channel Blockers - therapeutic use
Cardiovascular disease
Cardiovascular system
Combined Modality Therapy
Coronary Disease - therapy
Drug therapy
Humans
Medical research
Medical sciences
Myocardial Revascularization - methods
Pharmacology. Drug treatments
Randomized Controlled Trials as Topic
Recurrence
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Calcium channel antagonists possess a number of properties that may be beneficial after revascularization procedures. Therefore, we present an overview of the use of these drugs after percutaneous intervention in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT), and compare the results in CAVEAT with those in published randomized trials. Also reviewed are the use of calcium channel antagonists to control perioperative hypertension, reduce myocardial necrosis, and prevent arrhythmias during cardiopulmonary bypass.
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(96)00305-0